AZ13824374, CAS [[3040082-19-4]]

Produktübersicht

• Artikelname: AZ13824374, CAS [[3040082-19-4]]
• Artikelnummer: MCE-HY-136521
• Hersteller Artikelnummer: HY-136521
• Alternativnummer: MCE-HY-136521-25MG,MCE-HY-136521-2MG,MCE-HY-136521-10MG,MCE-HY-136521-5MG,MCE-HY-136521-10MMX1ML
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

AZ13824374 is a potent and selective ATAD2 bromodomain inhibitor (pIC50 of 6.9 in HCT116 cells). AZ13824374 disrupts chromatin interactions and gene transcription by binding to the acetyl-lysine binding site of the ATAD2 bromodomain. AZ13824374 has anticancer activity against breast cancer[1].

Produkteigenschaften

• Molekulargewicht: 562.68
• Reinheit: 99.22
• CAS Nummer: [3040082-19-4]
• Formel: C30H39FN8O2
• Target-Kategorie: Epigenetic Reader Domain

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound